Parathyroid disorders: Difference between revisions

	Parathyroid disorders
Overview
Classification Hyperparathyroidism Familial hypocalciuric hypercalcemia Hypoparathyroidism Pseudohypoparathyroidism
Diagnosis
Differentiating Parathyroid Disorders

VisualWikitext

Revision as of 17:47, 6 October 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]

Synonyms and keywords:

Overview

Classification

Parathyroid disorders

Hyperparathyroidism

Familial hypocalciuric hypercalcemia

Hypoparathyroidism

Parathyroid hormone resistance diseases

Primary

Secondary

Tertiary

Post-surgical

Autoimmune

Genetic defects associated

Functional

Pseudohypoparathyroidism

Acrodysostosis

Blomstrand chondrodysplasia

Pseudohypoparathyroidism type 1

Pseudohypoparathyroidism type 2

Acrodysostosis type 1

Acrodysostosis type 2

Type 1A

Type 1B

Type 1C

Pseudopseudohypoparathyroidism

Diagnosis

Disorder		Laboratory findings
Disorder		Parathyroid hormone	Serum calcium	Serum phosphate	Other findings
Hyperparathyroidism	Primary hyperparathyroidism	↑	↑	↓/Normal	Normal/↑ calcitriol
	Secondary hyperparathyroidism	↑	↓/Normal	↑	--
	Tertiary hyperparathyroidism	↑	↑	↑	--
Familial hypocalciuric hypercalcemia		Normal/↑	Normal/↑	--	↓ Urinary calcium/creatinine clearance ratio
Hypoparathyroidism		↓	↓	↑	↓ 1,25 Dihydroxy vitamin D Normal urinary cAMP Normal urinary phosphate
Pseudohypoparathyroidism	Pseudohypoparathyroidism type 1A	↑	↓	↑	↓ 1,25 Dihydroxy vitamin D ↓ Urinary cAMP ↓ Urinary phosphate
	Pseudohypoparathyroidism type 1B	↑	↓	↑	↓ 1,25 Dihydroxy vitamin D ↓ Urinary cAMP ↓ Urinary phosphate
	Pseudohypoparathyroidism type 1C	↑	↓	↑	↓ 1,25 Dihydroxy vitamin D ↓ Urinary cAMP ↓ Urinary phosphate
	Pseudopseudohypoparathyroidism	↑	↓	↑	↓ ↓ 1,25 Dihydroxy vitamin D Normal urinary cAMP ↓ Urinary phosphate
	Pseudohypoparathyroidism type 2	Normal	Normal	Normal	--
Acrodysostosis	Acrodysostosis type 1	↑	↓	↑	Multiple hormone resistance
Acrodysostosis	Acrodysostosis type 2	↑	↓	↑	Multiple hormone resistance
Blomstrand chondrodysplasia		↑	↓	↑	↓ Urinary phosphate ↑ Urinary cAMP

Differentiating Parathyroid Disorders

Parathyroid disorders usually cause an symptoms due to derangement in serum calcium. So, parathyroid disorders are differentiated within themselves and others on the basis of serum calcium levels.

Hypercalcemia

Repeat (Check ionized calcium or calcium corrected for albumin)

Hypercalcemia confirmed

Measure intact parathyroid hormone (PTH)

↑ PTH

Mildly ↑ PTH

↓ PTH

Hyperparathyroidism

Urinary calcium creatinine ratio

Measure parathyroid hormone-related protein (PTHrP) and vitamin D metabolites

↑ serum phosphate
History of renal transplantation

↓/Normal phosphate levels

↑ Urinary calcium creatinine ratio

↓ Urinary calcium creatinine ratio

Tertiary hyperparathyroidism

Primary hyperparathyroidism

Familial hypocalciuric hypercalcemia

↑ PTHrP

↑ 1,25-dihydroxy vitamin D

↑ 25-hydroxy vitamin D

↓ 1,25-dihydroxy vitamin D

Normal PTHrP and vitamin D metabolites

Humoral hypercalcemia of malignancy

Chest X-ray, ACE levels

Hypervitaminosis D

History of high milk intake,
excess calcium intake for treating osteoporosis or dyspepsia

Serum protein electrophoresis

Mammography

Check medications

Check for malignancies

Bilateral hilar lymphadenopathy, ↑ ACE levels

Lithium induced hypercalcemia

Thiazide diuretic induced hypercalcemia

A01=Hypercalcemia B01=Repeat (Check ionized calcium or Calcium corrected for albumin) C01=Hypercalcemia confirmed D01=Measure parathyroid hormone (PTH) E01=↑ parathyroid hormone|E02=Mildly ↑ parathyroid hormone|E03= ↓ parathyroid hormone F01=Hyperparathyroidism|F02=Urinary calcium creatinine ratio|F03=Measure parathyroid hormone related peptide (PTHrP) and vitamin D metabolites G01=↑ serum phosphate
History of renal transplantation|G02=↓/Normal phosphate levels|G03=↑ Urinary calcium creatinine ratio|G04=↓ Urinary calcium creatinine ratio H01=Tertiary hyperparathyroidism|H02=Primary hyperparathyroidism|H03= Familial hypocalceuric hypercalcemia| I01=↑ PTHrP|I02=↑ 1,25-dihydroxy vitamin D|I03=↑ 25-hydroxy vitamin D|I04=↓ 1,25-dihydroxy vitamin D|I05=Normal PTHrP and vitamin D metabolites| J01=Humoral hypercalcemia of malignancy|J02=Chest X-ray, ACE levels|J03=Hypervitaminosis D|J04=History of high milk intake
Excess calcium intake for treating osteoporosis or dyspepsia|J05=Serum protein electrophoresis|J06=Mammography|J07=Check medications K01=Bilateral hilar lympadenopathy, ↑ ACE levels|K02=Milk-alkali syndrome|K03=Multiple myeloma|K04=Breast cancer L01=Sarcoidosis|L02=Lithium induced hypercalcemia|L03=Thiazide diuretic induced hypercalcemia

@@ Line 172: / Line 172: @@
 {{Family tree| | | | | J01 | | | J02 | | | J03 | | | J04 | | J05 | | J06 | | J07 |J01=Humoral [[hypercalcemia]] of [[malignancy]]|J02=[[Chest X-ray]], [[ACE]] levels|J03=[[Hypervitaminosis D]]|J04=History of high milk intake,<br>excess [[calcium]] intake for treating [[osteoporosis]] or [[dyspepsia]]|J05=[[Serum protein electrophoresis]]|J06=[[Mammography]]|J07=Check medications}}
 {{Family tree| | | | | |!| | | | |!| | | | | | | | | |!| | | |!| | | |!| | | |!| |}}
-{{Family tree| | | | | K01 | | | K02 | | | | | | | | K03 | | K04 | | K05 | | |!| |K01=Check for [[malignancies]]|K02=Bilateral hilar [[lympadenopathy]], ↑ [[ACE]] levels|K03=[[Milk-alkali syndrome]]|K04=[[Multiple myeloma]]|K05=[[Breast cancer]]}}
+{{Family tree| | | | | K01 | | | K02 | | | | | | | | K03 | | K04 | | K05 | | |!| |K01=Check for [[malignancies]]|K02=Bilateral hilar [[lymphadenopathy]], ↑ [[ACE]] levels|K03=[[Milk-alkali syndrome]]|K04=[[Multiple myeloma]]|K05=[[Breast cancer]]}}
 {{Family tree| | | | | | | | | | |!| | | | | | | | | | | | | | | | |,|-|-|-|-|^|.| | |}}
 {{Family tree| | | | | | | | | | L01 | | | | | | | | | | | | | | | |L02 | | | | L03 | |L01=[[Sarcoidosis]]|L02=[[Lithium]] induced hypercalcemia|L03=[[Thiazide diuretic]] induced hypercalcemia}}